Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T03:07:47.486Z Has data issue: false hasContentIssue false
  • English
  • Français

Should patients manage their own oral anticoagulation therapy?

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  09 October 2003

M Marzonlini  and
Hilary Wynne
M Marzonlini
Affiliation:
Newcastle-upon-Tyne Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Hilary Wynne
Affiliation:
Newcastle-upon-Tyne Hospitals NHS Trust, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Oral anticoagulant therapy has become more commonly prescribed for people of 65 years and over following the widening of its clinical indications to include thromboembolic prophylaxis in atrial fibrillation. It is estimated that approximately 470 000 people in the UK, almost 1% of the population, are currently receiving oral anticoagulant therapy and this is growing. Due to its narrow therapeutic index, and the intra-individual variation in dose requirement, there is a need to monitor the level of anticoagulation in each patient. In consequence, health systems have had to invest resources into monitoring services to cope with this development.

Type
Editorial
Information
Reviews in Clinical Gerontology , Volume 12 , Issue 4 , November 2002 , pp. 275 - 281
Copyright
© 2002 Cambridge University Press